<DOC>
	<DOCNO>NCT01665404</DOCNO>
	<brief_summary>This single-center , open-label , cross-over study evaluate effect fluvoxamine pharmacokinetics RO4917523 healthy volunteer . Healthy volunteer receive single dose RO4917523 alone combination multiple dos fluvoxamine cross-over design . The anticipated time study treatment 40 day .</brief_summary>
	<brief_title>A Study Effect Fluvoxamine Pharmacokinetics RO4917523 Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Fluvoxamine</mesh_term>
	<criteria>Healthy volunteer , 1865 year age inclusive Nonsmokers Body mass index ( BMI ) 18 30 mg/m2 inclusive Women menopausal surgically sterile agree use two adequate method contraception Evidence active chronic disease History significant disease ( e.g. , cardiovascular , hepatic , renal ) cancer History presence clinically significant psychiatric condition Any condition disease would render volunteer unsuitable study , place volunteer undue risk interfere ability volunteer complete study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>